San***arg

Senior Director Business Development

学歴

University of Rome "Tor Vergata"

University of Rome "Tor Vergata" (2001 - 2004)

  • Degree: PhD
  • Field of Study: Biotechnology (Immunology)
  • Description: PhD in Immunology

GGD University, Bilaspur, India (1996 - 1998)

  • Degree: MSc
  • Field of Study: Biotechnology
  • Description: MS in Biotechnology

G.G.D University, Bilaspur, India (1994 - 1996)

  • Degree: Bachelor of Science (B.Sc.)
  • Field of Study: Biology, Chemistry
  • Description:

スキル:

Tumor Immunology, Managerial, Autoimmune Diseases, Immunology

職務経験:

Senior Director Business Development at Labcorp

  • Location: San Francisco Bay Area
  • Duration: 2021-08 to Present
  • Description: Supporting global Central Laboratory Services to the emerging biotech / biopharma sector located throughout the Western United States. Focused services include: central laboratory testing, biomarker and assay development, specimen management, project management, external lab management, biobanking and digital pathology.

Senior Director, Business Development (Clinical Testing and Lab Services) at Precision For Medicine

  • Location: Redwood City, CA
  • Duration: 2019-01 to 2021-08
  • Description: At Precision for Medicine, I was providing US-wide immune monitoring, bioanalytical and translational lab services/sales support to Oncology, Autoimmune, and ORD trials. Supporting prospecting, scientific presentation at client meeting and generating trial-specific budget as well as study-specific proposal. Supporting regional BD's to reduce sale-cycle by efficiently integrating my Immunology knowledge and solution-based selling approach. Precision for Medicine is a global organization providing RnD, commercial and payer solutions to the life sciences industry. We provide a comprehensive and integrated set of services that help accelerate research, enable market adoption, enhance patients outcomes and realize the full commercial potential of new therapies and products.

Account Manager at STEMCELL Technologies

  • Location: San Francisco Bay Area
  • Duration: 2015-03 to 2019-01
  • Description:  Designed and implemented strategic sales plan to grow STEMCELL business in biotech, pharma and academic institutions both in the East Coast and in the Bay Area territories.  Member of various internal team responsible for planning and implementing development of biospecimen business in the US or penetrating in the Indian life science market.  Expertise in using CRM (SFDC) for managing business processes.  Coordinate with appropriate team regarding budgeting and risk assessment.  Exceeded annual sales target every year. Achieved FY18 ~50% growth (~130% of plan) and FY19 ~75% growth (~150% plan) in revenue by winning over competitions, new business and better territory management.  Secured a place in the President’s Club (top 5 sales performer) in FY2018 and FY2019.

Assistant Professor, Research at University of Michigan

  • Location: Ann Arbor, Michigan
  • Duration: 2012-07 to 2015-03
  • Description: • Aging influences epigenetic marks and susceptibility to different diseases. Demonstrated that changes in DNA methylation in-utero, delay the onset of rheumatoid arthritis, atherosclerosis plaque, and associated inflammation in progeny (F1) mice. We are working on targeting these epigenetically modifiable genes in the search of a novel therapy for these diseases. • Links between aging, immune senescence and susceptibility to autoimmunity and cancer. 1. Investigating a mechanism to explain the paradoxical relationship between aging and inflammation, where the number of regulatory T cells (Tregs) increases with age, yet there is increased (rather than decreased) inflammation. This will lead to translational studies focused on modulating Treg function to treat cancer/inflammatory diseases in the elderly. 2. Studying how aging affects dendritic cell (DC)-mediated anti-tumor surveillance. This work defines the mechanism of age-dependent alteration of DC function, and tests ways to improve DC function and DC vaccine design against various cancers.

Research Investigator at University of Michigan

  • Location: Ann Arbor, MI
  • Duration: 2007-07 to 2012-06
  • Description: • T cells in the regulation of auto-immune and CNS diseases. Identified temporal regulation of T-cell mediated inflammatory response as a mechanism that balances the beneficial and pathogenic role of astrocytes in CNS injury. Demonstrated, that glutathione synthesis and γ-glutamyl pathways, that are essential for T cell activation, are suppressed by Treg cells. The finding opens a new avenue of research for future therapies of conditions ranging from autoimmune to organ transplants to cancer.
AI履歴書分析

候補者インテリジェンスレポート

米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。

キャリアの継続性とリスク評価

Employment GapLow

No noticeable employment gaps across the career timeline; continuous progression from academia to industry with overlapping senior roles.

Industry ConsistencyLow

Career remains within life sciences (academia, biotech, CRO/clinical testing, and lab services), indicating strong industry consistency with domain-relevant experience.

Tenure StabilityLow

Typical tenure lengths (3–5 years in academia and 2–5 years in industry roles) without abrupt short stints, suggesting stability and sustained performance.

Education-Career MatchLow

Education at University of Rome Tor Vergata plus senior academic roles align with a high-level immunology/biomedical background; while the exact degree isn't listed, the track record indicates a strong match for US-based senior roles.

キャリア成長カーブ

Research Investigator Entry
University of Michigan
2007-07 to 2012-06
Assistant Professor, Research ↑ 昇進
University of Michigan
2012-07 to 2015-03
Account Manager Lateral
STEMCELL Technologies
2015-03 to 2019-01
Senior Director, Business Development (Clinical Testing and Lab Services) ↑ 昇進
Precision For Medicine
2019-01 to 2021-08
Senior Director Business Development Lateral
Labcorp
2021-08 to Present
評価:The candidate shows a clear upward trajectory from research roles into senior business development leadership in life sciences. The mix of academic and CRO/biotech BD experience, with domain expertise in immunology and oncology, suggests readiness for senior executive BD or strategic partnerships leadership roles in the next 2-3 years.

最適な役職(トップ5)

1

Vice President / Global Head of Strategic Partnerships - Immuno-Oncology95% 適合

Extensive BD leadership in immunology and oncology with proven success in securing biomarker, lab services, and translational partnerships; aligns with high-impact revenue growth and cross-border collaborations.

2

Global Head of Business Development - Clinical Trials Services / Biomarker Analytics92% 適合

Direct experience in immune monitoring, bioanalytical and translational lab services; strong track record in US-wide BD and program budgeting, ideal for global CRO/Lab Services leadership.

3

Senior Vice President of Business Development - Immunology/Autoimmune Biotech88% 適合

Deep domain expertise in autoimmune and immuno-oncology spaces with leadership in BD; capable of shaping strategic growth, partnerships, and product/service integration.

4

Director / VP of Commercial Growth - Central Lab & Biomarker Services82% 適合

Strong alignment with central lab/biomarker capabilities, experience driving revenue growth and client engagements across biotech/pharma segments.

5

Head of Strategic Partnerships - Diagnostics / Immunoassays78% 適合

Solid immunoassay development and biomarker discovery background; suitable for diagnostic partnerships and collaboration-driven growth, albeit narrower scope than top roles.

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保